This trial will enroll experienced dual cannabis-tobacco smokers to study the effects of smoking and vaping dry herb cannabis. It will compare THC and toxicant exposure, subjective and cardiovascular effects, and cardiovascular disease risk between smoking cannabis and smoking tobacco cigarettes.
- Cannabis Use
- Cannabis Smoking
- Nicotine Addiction
- Smoking/Cigarette Smoking
- Tobacco Use
- Nicotine Withdrawal
- Cardiovascular Risk
15 Primary · 9 Secondary · Reporting Duration: Days 1-2 of each arm
0 Treatment Group
18 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is this research endeavor recruiting participants presently?
"Yes, the information provided on clinicaltrials.gov shows that this research endeavour is actively enrolling patients. Originally posted 10/30/2020 and most recently updated 8/2/2022, 18 participants are being sought from 2 distinct sites." - Anonymous Online Contributor
What does this clinical experiment seek to achieve?
"The main outcome being monitored during the first two days of cannabis administration is maximal change in expired carbon monoxide levels. Secondary outcomes include assessing cardiovascular effects by measuring heart rate, comparing toxicant exposure through CO measurements, and examining epinephrine excretion via urine catecholamines." - Anonymous Online Contributor
How many participants are partaking in this scientific experiment?
"Affirmative. Clinicaltrials.gov data suggests that this medical trial, initially posted on October 30th 2020 is currently recruiting participants. 18 patients will be admitted at 2 study sites for the duration of the research project." - Anonymous Online Contributor